Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.40 |
| ▸ | FEN1 | P39748 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | XDH | P47989 | 2/20 | 0.36 |
| ▸ | KIF11 | P52732 | 4/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26777534 | 0.97 | ALOX5AP (0.38) | ALOX5APFEN1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL25660295 | 0.92 | ALOX5AP (0.40) | ALOX5APFEN1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL25660556 | 0.92 | KIF11 (0.44) | ALOX5APFEN1XDHKIF11PTPN5 | |
| SCHEMBL25660553 | 0.91 | KIF11 (0.40) | ALOX5APFEN1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL25660656 | 0.91 | ALOX5AP (0.39) | ALOX5APFEN1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL25660293 | 0.91 | ALOX5AP (0.35) | ALOX5APFEN1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL26777546 | 0.91 | ALOX5AP (0.38) | ALOX5APFEN1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL25660428 | 0.91 | AR (0.43) | ALOX5APFEN1SMN1; SMN2ALDH1A1XDH | |
| SCHEMBL25660313 | 0.90 | ALOX5AP (0.42) | ALOX5APFEN1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL25660476 | 0.90 | ALOX5AP (0.38) | ALOX5APFEN1SMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11825743-B2 | Organic molecules for use in organic optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
| EP-3585777-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2023-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11825743-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OCIAD2 | ALOX5AP 3126/4885FEN1 1566/4885SMN1; SMN2 4433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.